← Open Payments lookup

LILIAN IKE: Open Payments

NPI 1851806574 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,573 in 72 payments from 9 companies in 2025. Trend: 2023 $839 · 2024 $942 · 2025 $1,573

Food & beverage: $1,573
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$371
Supernus Pharmaceuticals, Inc.41$344
Janssen Pharmaceuticals, Inc7$236
Teva Pharmaceuticals USA, Inc.9$229
E.R. Squibb & Sons, L.L.C.5$149
Alkermes, Inc.1$125
Otsuka America Pharmaceutical, Inc.3$68
Lundbeck LLC1$27
Almatica Pharma LLC1$26

Products named: Qelbree, UZEDY, INVEGA, COBENFY, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, REXULTI.

Industry payments across TX — which companies pay providers there.